João Mariano Pêgo

Suggest Changes
Learn More
Dabigatran Etexilate (DE)was the first oral direct thrombin inhibitor approved for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (AF) [1,2]. One of(More)